CRYSTALLINE LEVODOPA AMIDE FREE BASE AND METHODS OF MAKING AND USING SAME

摘要

A crystalline levodopa amide free base and a process of making it are provided. Particularly, a substantially pure crystalline levodopa amide free base is disclosed, suitable for the preparation of pharmaceutical compositions for treatment of diseases or disorders characterized by neurodegeneration and/or reduced levels of brain dopamine such as Parkinson's disease.